Generic medications in ophthalmology

Matt Zore, Alon Harris, Leslie Abrams Tobe, Brent Siesky, Ingrida Januleviciene, Jennifer Behzadi, Annahita Amireskandari, Patrick Egan, Kevin Garff, Barbara Wirostko

Research output: Contribution to journalReview article

17 Scopus citations

Abstract

The purpose of this review is to discuss the process of genericisation of medications in the US and Europe with a focus on ophthalmic drugs. Regulatory guidelines of the US Food and Drug Administration and the European Medicines Agency will be discussed, and the advantages and concerns of genericisation will be explored. We will look at various studies concerning the safety and efficacy of generic drugs compared to their branded counterparts. In particular, the challenges of assuring bioequivalence and therapeutic equivalence in topical ophthalmic drugs will be examined.

Original languageEnglish (US)
Pages (from-to)253-257
Number of pages5
JournalBritish Journal of Ophthalmology
Volume97
Issue number3
DOIs
StatePublished - Mar 1 2013

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Generic medications in ophthalmology'. Together they form a unique fingerprint.

  • Cite this

    Zore, M., Harris, A., Tobe, L. A., Siesky, B., Januleviciene, I., Behzadi, J., Amireskandari, A., Egan, P., Garff, K., & Wirostko, B. (2013). Generic medications in ophthalmology. British Journal of Ophthalmology, 97(3), 253-257. https://doi.org/10.1136/bjophthalmol-2012-302245